Holen Sie sich die Stockscreener-App
9.605
1.53%
0.145
Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
45.51%
9.238
|
16.95 | 13.80 | 13.29 | 11.49 |
| Operating Expenses |
42.88%
35.31
|
61.82 | 59.84 | 62.41 | 50.25 |
| Operating Income/Loss |
41.88%
-26.07
|
-44.87 | -46.04 | -49.11 | -38.77 |
| Nonoperating Income/Loss |
2,490%
42.97
|
-1.798 | -1.287 | 0.893 | 0.492 |
Net Income/Loss
|
136.22%
16.90
|
-46.66 | -47.24 | -48.22 | -38.27 |
| Basic Average Shares |
36.68%
320.01
|
234.14 | - | 227.98 | 227.28 |
| Diluted Average Shares |
40.42%
328.78
|
234.14 | - | 227.98 | 227.28 |
| Basic Earnings Per Share |
125.00%
0.05
|
-0.20 | - | -0.21 | -0.17 |
| Diluted Earnings Per Share |
60.00%
-0.08
|
-0.20 | - | -0.21 | -0.17 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):